Help
RSS
API
Feed
Maltego
Contact
Domain > www.opzelura.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2024-05-29
104.22.4.172
(
ClassC
)
2024-09-21
104.22.5.172
(
ClassC
)
2025-04-07
172.67.10.241
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Wed, 29 May 2024 19:07:30 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveCache-Control: max-age3600Expires: Wed, 29 May 2024 20:07:30 GMTLocatio html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>cloudflare/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Wed, 29 May 2024 19:07:30 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-aliveCF-Ray: 88b8c48b397ca34a-SEACF-Cache-Status: DYNAMICAge: 32033Cac !DOCTYPE html>html langen dirltr prefixog: https://ogp.me/ns#> head> meta charsetutf-8 />meta namedescription contentLearn about treatment with OPZELURA® across all uses on the official patient website. See Important Safety Information and Full Prescribing Information, including Boxed Warning. />link relcanonical hrefhttps://www.opzelura.com/ />link relshortlink hrefhttps://www.opzelura.com/ />link relapple-touch-icon hrefsites/g/files/hssmmz5276/files/2023-02/apple-touch-icon.png />link relapple-touch-icon sizes120x120 hrefsites/g/files/hssmmz5276/files/2023-02/apple-touch-icon.png />link relapple-touch-icon-precomposed hrefsites/g/files/hssmmz5276/files/2023-02/apple-touch-icon.png />link relapple-touch-icon-precomposed sizes120x120 hrefsites/g/files/hssmmz5276/files/2023-02/apple-touch-icon.png />meta namegoogle-site-verification contentp5QBpOKY0S4A-PDk58ohyHquUxVUfJfbbGSLVMSlNl0 />meta nameGenerator contentDrupal 10 (https://www.drupal.org) />meta nameMobileOptimized contentwidth />meta nameHandheldFriendly contenttrue />meta nameviewport contentwidthdevice-width, initial-scale1, shrink-to-fitno />script typeapplication/ld+json>{@context:http://schema.org,@type:ItemList,itemListElement:{@type: SiteNavigationElement,position: 1,name: Atopic Dermatitis,url:https://www.opzelura.com/atopic-dermatitis/},{@type: SiteNavigationElement,position: 2,name: Vitiligo,url:https://www.opzelura.com/vitiligo/}}/script>script typeapplication/ld+json>{@context:http://schema.org, @graph: {@context: http://schema.org, type: MedicalCondition, name: Atopic dermatitis (AD), sameAs: https://en.wikipedia.org/wiki/Atopic_dermatitis, code: L20. 9, possibleTreatment:{@type: MedicalTherapy, drug:{@type: Drug,name: OPZELURA (ruxolitinib),proprietaryName: OPZELURA, nonProprietaryName: Ruxolitinib cream,mainEntityOfPage: https://www.opzelura.com/atopic-dermatitis/, dosageForm: 1.5%,administrationRoute: topical,drugUnit: Cream,activeIngredient: ruxolitinib,availableStrength: 1.5% ruxolitinib cream,mechanismOfAction: Topical JAK inhibitio
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]